Home
NICE Guidance
Conditions and diseases
Neurological conditions
Parkinson's disease, tremor and dystonia
Parkinson’s disease with end-of-dose motor fluctuations: opicapone
Evidence summary [ES9]
Published:
21 March 2017
Key points
Introduction and current guidance
Product overview
Evidence review
Estimated impact for the NHS
Information for the public about medicines
Relevance to other NICE programmes
References
Evidence table
Results tables
Excluded studies
Terms used in this evidence summary
Search strategy
Development of this evidence summary
Download (PDF)
Advice
Next
Excluded studies
Excluded studies
No studies were excluded in the second sift.